INCY

Quote

Short

News

Articles

Message Board

Incyte Corporation (NASDAQ : INCY ) News

Incyte Corporation (NASDAQ: INCY) News Releases

INCY News Releases

June 04, 2026 08:05:00 am

Business Wire

Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

June 01, 2026 10:00:28 am

SeekingAlpha

These 10 large-cap healthcare giants rank among the market's most attractively valued stocks

May 30, 2026 01:46:37 pm

SeekingAlpha

Incyte lymphoma therapy lifts cancer-free survival by 25% in late-stage trial

May 30, 2026 08:00:00 am

Business Wire

Incyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBC

May 26, 2026 08:00:00 am

Business Wire

Incyte to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

May 21, 2026 06:15:07 pm

KlickAnalytics

INCY Price Target Alert: $99.00. Issued by Bernstein

May 20, 2026 08:54:17 am

SeekingAlpha

Incyte-Genesis expands AI drug discovery deal with $120M funding and new targets

May 20, 2026 08:00:00 am

Business Wire

Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery

May 19, 2026 01:40:43 pm

SeekingAlpha

Incyte Corporation (INCY) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

May 19, 2026 09:44:04 am

SeekingAlpha

Value or Growth? These 20 stocks offer both as markets hover near record highs

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account